Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001247261 | SCV001420670 | uncertain significance | Familial Mediterranean fever | 2021-08-27 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with threonine at codon 208 of the MEFV protein (p.Ser208Thr). The serine residue is moderately conserved and there is a small physicochemical difference between serine and threonine. This variant is present in population databases (rs759326778, ExAC 0.01%). This missense change has been observed in individual(s) with familial Mediterranean fever (PMID: 30355575). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 971473). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects MEFV function (PMID: 30355575). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome Diagnostics Laboratory, |
RCV002264251 | SCV002542296 | uncertain significance | Autoinflammatory syndrome | 2018-05-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001247261 | SCV003802290 | uncertain significance | Familial Mediterranean fever | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003127733 | SCV003802291 | likely benign | Familial Mediterranean fever, autosomal dominant | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003127734 | SCV003802292 | likely benign | Acute febrile neutrophilic dermatosis | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235515 | SCV003934373 | uncertain significance | not specified | 2023-05-22 | criteria provided, single submitter | clinical testing | Variant summary: MEFV c.623G>C (p.Ser208Thr) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.8e-05 in 238594 control chromosomes (gnomAD). c.623G>C has been reported in the literature in two homozygous siblings affected with familial autoinflamation (Hong_2019). The unaffected sibling and parents were heterozygous with the variant, showing some evidence of cosegregation with disease. These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on cell death, finding a significant increase in spontaneous cell death in macrophages transfected with the variant construct (Honda_2021). The following publications have been ascertained in the context of this evaluation (PMID: 26215181, 30355575, 33733382). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |